JACC: Case Reports (Dec 2020)
Use of TandemHeart as Bridge to Recovery for Antibody-Mediated Rejection in a Heart Transplant Patient
- Juan P. Rodriguez-Escudero, MD,
- Antonio Duran, MD,
- Clement Eiswirth, MD,
- Stacy A. Mandras, MD,
- Sapna V. Desai, MD,
- Hamang M. Patel, MD,
- Rajan Patel, MD,
- Hector O. Ventura, MD,
- Selim R. Krim, MD
Affiliations
- Juan P. Rodriguez-Escudero, MD
- Section of Cardiomyopathy and Heart Transplantation, Division of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, The University of Queensland School of Medicine, New Orleans, Louisiana, USA
- Antonio Duran, MD
- Section of Cardiomyopathy and Heart Transplantation, Division of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, The University of Queensland School of Medicine, New Orleans, Louisiana, USA
- Clement Eiswirth, MD
- Section of Cardiomyopathy and Heart Transplantation, Division of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, The University of Queensland School of Medicine, New Orleans, Louisiana, USA
- Stacy A. Mandras, MD
- Section of Cardiomyopathy and Heart Transplantation, Division of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, The University of Queensland School of Medicine, New Orleans, Louisiana, USA; Department of Medicine, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana, USA
- Sapna V. Desai, MD
- Section of Cardiomyopathy and Heart Transplantation, Division of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, The University of Queensland School of Medicine, New Orleans, Louisiana, USA
- Hamang M. Patel, MD
- Section of Cardiomyopathy and Heart Transplantation, Division of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, The University of Queensland School of Medicine, New Orleans, Louisiana, USA
- Rajan Patel, MD
- Section of Cardiomyopathy and Heart Transplantation, Division of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, The University of Queensland School of Medicine, New Orleans, Louisiana, USA; Department of Medicine, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana, USA
- Hector O. Ventura, MD
- Section of Cardiomyopathy and Heart Transplantation, Division of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, The University of Queensland School of Medicine, New Orleans, Louisiana, USA; Department of Medicine, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana, USA
- Selim R. Krim, MD
- Section of Cardiomyopathy and Heart Transplantation, Division of Cardiology, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, The University of Queensland School of Medicine, New Orleans, Louisiana, USA; Department of Medicine, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana, USA; Address for correspondence: Dr. Selim R. Krim, Section of Cardiomyopathy and Heart Transplantation, John Ochsner Heart and Vascular Institute, Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, Lousiana 70121, USA.
- Journal volume & issue
-
Vol. 2,
no. 15
pp. 2358 – 2362
Abstract
Antibody-mediated rejection is a major cause of graft failure, mortality, and morbidity among cardiac transplant recipients. We present the first reported case of TandemHeart (LivaNova, Pittsburgh, Pennsylvania) used in the management of antibody-mediated rejection associated with cardiogenic shock. (Level of Difficulty: Advanced.)
